A pilot study of GC/MS-based serum metabolic profiling of acute rejection in renal transplantation

Transplant Immunology

Volumn 19, Issue 1, 2008, Pages 74-80

  Mao, You ying ^a   Bai, Jing qing ^b   Chen, Jiang hua ^a,c   Shou, Zhang fei ^a   He, Qiang ^a   Wu, Jian yong ^a   Chen, Ying ^a   Cheng, Yi yu ^b  

^a Affiliated Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute allograft rejection; Gas chromatograph mass spectrometry (GC MS); Kidney transplantation; Metabolic profiling; Metabolomics

Indexed keywords

ALANINE; AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; CD3 ANTIBODY; CYCLOSPORIN A; FATTY ACID; FRUCTOSE; GALACTOSE; GLUCOSE; GLYCINE; INOSITOL; LACTIC ACID; LEUCINE; LIPID; LYMPHOCYTE ANTIBODY; MALONIC ACID DERIVATIVE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYRISTIC ACID; OKT 3; OXIME; PHENYLALANINE; PREDNISONE; RAPAMYCIN; SERINE; TACROLIMUS; THREONINE; UREA; VALINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; MALE; MASS FRAGMENTOGRAPHY; PILOT STUDY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RECIPIENT;

ADULT; AMINO ACIDS; CARBOHYDRATES; CARBOXYLIC ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; METABOLISM; MIDDLE AGED; PILOT PROJECTS; PRINCIPAL COMPONENT ANALYSIS;

EID: 40849086337     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.01.006     Document Type: Article

References (30)

1. Xin Lu D.L.P. A systems biology view of allograft rejection. Curr Opin Organ Transpl 10 10 (2005) 28-34
2. Flechner S.M., Kurian S.M., Head S.R., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transpl 4 9 (2004) 1475-1489
3. O'Riordan E., and Goligorsky M.S. Emerging studies of the urinary proteome: the end of the beginning?. Curr Opin Nephrol Hypertens 14 6 (2005) 579-585
4. Voshol H., Brendlen N., Muller D., et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J Proteome Res 4 4 (2005) 1192-1199
5. Wishart D.S. Metabolomics: the principles and potential applications to transplantation. Am J Transpl 5 12 (2005) 2814-2820
6. Schauer N., and Fernie A.R. Plant metabolomics: towards biological function and mechanism. Trends Plant Sci (2006)
7. Whitfield P.D., German A.J., and Noble P.J. Metabolomics: an emerging post-genomic tool for nutrition. Br J Nutr 92 4 (2004) 549-555
8. German J.B., Bauman D.E., Burrin D.G., et al. Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr 134 10 (2004) 2729-2732
9. Lindon J.C., Holmes E., and Nicholson J.K. Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 6 3 (2004) 265-272
10. Watkins S.M., and German J.B. Metabolomics and biochemical profiling in drug discovery and development. Curr Opin Mol Ther 4 3 (2002) 224-228
11. Sabatine M.S., Liu E., Morrow D.A., et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112 25 (2005) 3868-3875
12. Brindle J.T., Antti H., Holmes E., et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H NMR-based metabonomics. Nat Med 8 12 (2002) 1439-1444
13. Foxall P.J., Mellotte G.J., Bending M.R., Lindon J.C., and Nicholson J.K. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 43 1 (1993) 234-245
14. Serkova N., Fuller T.F., Klawitter J., Freise C.E., and Niemann C.U. H NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 67 3 (2005) 1142-1151
15. Salaman J.R. Monitoring of rejection in renal transplantation. Immunol Lett 29 1-2 (1991) 139-142
16. Alan Saghatelian B.F.C. Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol 9 (2005) 62-68
17. Griffin J.L. Understanding mouse models of disease through metabolomics. Curr Opin Chem Biol 10 (2006) 1-7
18. Nobeli I., and Thornton J.M. A bioinformatician's view of the metabolome. Bioessays 28 5 (2006) 534-545
19. Jonsson P., Gullberg J., Nordstrom A., et al. A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. Anal Chem 76 6 (2004) 1738-1745
20. Jonsson P., Johansson A.I., Gullberg J., et al. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 77 17 (2005) 5635-5642
21. Wu J.Y., Chen J.H., Wang Y.M., He Q., and Wu D.B. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplantation 78 5 (2004) 713-718
22. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 2 (1999) 713-723
23. Segura J., Ventura R., and Jurado C. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J Chromatogr B Biomed Sci Appl 713 1 (1998) 61-90
24. Denkert C., Budczies J., Kind T., et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res 66 22 (2006) 10795-10804
25. Sarwal M., Chua M.S., Kambham N., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 349 2 (2003) 125-138
26. Schaub S., Rush D., Wilkins J., et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15 1 (2004) 219-227
27. O'Riordan E., Orlova T.N., Mei J.J., et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 15 12 (2004) 3240-3248
28. Anthony M.L., Sweatman B.C., Beddell C.R., Lindon J.C., and Nicholson J.K. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmacol 46 1 (1994) 199-211
29. Robertson D.G., Reily M.D., Sigler R.E., et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 57 2 (2000) 326-337
30. Hauet T., Baumert H., Gibelin H., et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 41 4 (2000) 280-291